Bilasi is a second-generation antihistamine used for the effective management of allergic conditions by selectively blocking peripheral H1 histamine receptors responsible for allergy symptoms. It is indicated for the relief of seasonal and perennial allergic rhinitis as well as chronic urticaria, helping to reduce sneezing, nasal discharge, itching, watery eyes, and skin reactions associated with hypersensitivity responses. Bilasi provides sustained control of allergic symptoms, improving daily comfort and quality of life in patients suffering from both acute and long-term allergic disorders. It is suitable for adult and pediatric use in clinically appropriate cases, offering a well-tolerated option in modern allergy management with targeted peripheral action and minimal central nervous system involvement.